Medicine and Dentistry
Breast Cancer
100%
Tumor Microenvironment
72%
Metastatic Carcinoma
58%
Racial Disparity
42%
Estrogen Receptor
37%
Neoplasm
36%
Recurrence Free Survival
32%
Breast Tumor
26%
Neoadjuvant Chemotherapy
25%
Lumpectomy
23%
Recurrent Disease
21%
Malignant Neoplasm
20%
Breast Carcinoma
19%
Magnetic Resonance Imaging
18%
Predictive Factor
18%
Cancer Diagnosis
18%
Disease Exacerbation
18%
Blood Vessel Permeability
18%
Breast Cancer-Related Lymphedema
18%
Pooled Analysis
18%
Intraoperative Radiation Therapy
18%
Retrospective Study
18%
Salivary Gland
18%
Pathologist
18%
Mucoepidermoid Carcinoma
18%
Systematic Review
18%
Surgical Infection
18%
Diagnosis
16%
Disease
15%
Intraductal Carcinoma
13%
Mastectomy
10%
Salivary Gland Neoplasm
9%
Ex Vivo
9%
Cell Transduction
9%
Immunocompetent Cell
7%
Sentinel Lymph Node Biopsy
7%
Mammography
7%
Macrophage
7%
Odds Ratio
7%
Retroperitoneal Lymph Node Dissection
6%
Axillary Lymph Node
6%
Hazard Ratio
6%
Surgery
6%
Proportional Hazards Model
6%
Gamma Urogastrone
6%
Epidermal Growth Factor Receptor 2
6%
Progesterone Receptor
6%
Immunofluorescence
5%
Lymph Node
5%
M2 Macrophages
5%
Keyphrases
Tumor Microenvironment
37%
Racial Disparities
25%
Breast Cancer
23%
Metastasis Tumor Microenvironment
22%
Cancer Cell Dissemination
20%
Distant Recurrence
19%
Black Men
18%
Breast Tumor Microenvironment
18%
Tissue Analysis
18%
DNA Methyltransferase 1 (DNMT1)
18%
Neoadjuvant Chemotherapy
18%
Nipple
18%
Breast Cancer-related Lymphedema
18%
Intravital Imaging
18%
Multiple Endocrine Neoplasia Type 1 (MEN1)
18%
Ethnically Diverse Populations
18%
Tumor-targeted Delivery
18%
TMEM Doorways
18%
Synchronous Bilateral Breast Cancer
18%
Single-cell Dynamics
18%
Breast Cancer Diagnosis
18%
Dissemination Risk
18%
Positive Margins
18%
Fixed Tissue
18%
Mucoepidermoid
18%
Vascular Permeability
18%
Disease Progression
18%
DNA Hypermethylation
18%
Axillary Reverse Mapping
18%
Underserved
18%
Breast
18%
Tumorigenesis
18%
Lumpectomy
18%
Re-excision
18%
Clinical Utility
18%
Bilateral Breast Cancer
14%
Ethnic Minorities
11%
Immune Cells
11%
Distant Relapse
11%
Inter-block
9%
Peptide Conjugation
9%
Re-excision Rate
8%
Pro-metastatic
7%
Metastatic Tumor
7%
High Density
7%
Breast Cancer Mortality
7%
Disparities in Outcome
7%
M2 Macrophages
7%
Angiogenesis
7%
Axillary Lymph Node Dissection
6%